Missouri S&T Scholar's Mine Research RepositoryMissouri S&T Research
print 
Title: Assessing treatment effect heterogeneity in clinical trials with blocked binary outcomes
Author (s): Albert, Jeffrey M.
Gadbury, Gary L.
Mascha, Edward J.
Department/Lab Affiliations: Mathematics & Statistics
Keywords: Bounds
Causal effects
Randomized block design
Subject-treatment interaction
Subject Terms: Counterfactuals logic.
Issue Date: 2005
Publisher: John Wiley & Sons
Citation: Jeffrey M. Albert, Gary L. Gadbury, and Edward J. Mascha (2005). Assessing Treatment Effect Heterogeneity in Clinical Trials with Blocked Binary Outcomes. Biometrical Journal, 47, 662 – 673.
Abstract: This paper addresses treatment effect heterogeneity (also referred to, more compactly, as treatment heterogeneity) in the context of a controlled clinical trial with binary endpoints. Treatment heterogeneity, variation in the true (causal) individual treatment effects, is explored using the concept of the potential outcome. This framework supposes the existance of latent responses for each subject corresponding to each possible treatment. In the context of a binary endpoint, treatment heterogeniety may be represented by the parameter, 2, the probability that an individual would have a failure on the experimental treatment, if received, and would have a success on control, if received. Previous research derived bounds for 2 based on matched pairs data. The present research extends this method to the blocked data context. Estimates (and their variances) and confidence intervals for the bounds are derived. We apply the new method to data from a renal disease clinical trial. In this example, bounds based on the blocked data are narrower than the corresponding bounds based only on the marginal success proportions. Some remaining challenges (including the possibility of further reducing bound widths) are discussed. (© 2005 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim)
Type: Article - Journal
text
In Title: Biometrical Journal
Copyright Notice: This material is presented to ensure timely dissemination of scholarly and technical work. Copyright and all rights therein are retained by authors or by other copyright holders. All persons copying this information are expected to adhere to the terms and constraints invoked by each author's copyright. In most cases, these works may not be reposted without the explicit permission of the copyright holder.
FULL COPYRIGHT INFORMATION:
http://www.wiley.com/WileyCDA/Section/id-301854.html
Publisher URL:
http://dx.doi.org/10.1002/bimj.200510157
Link to this page:
http://scholarsmine.mst.edu/post_prints/AssessingTreatmentEffectHeteroge_09007dcc804f0868.html



titleAssessing treatment effect heterogeneity in clinical trials with blocked binary outcomes
contributor.authorAlbert, Jeffrey M.
contributor.authorGadbury, Gary L.
contributor.authorMascha, Edward J.
contributor.deptlabMathematics & Statistics
subjectBounds
subjectCausal effects
subjectRandomized block design
subjectSubject-treatment interaction
subject.LCSHCounterfactuals logic.
date.issued2005
publisherJohn Wiley & Sons
identifier.citationJeffrey M. Albert, Gary L. Gadbury, and Edward J. Mascha (2005). Assessing Treatment Effect Heterogeneity in Clinical Trials with Blocked Binary Outcomes. Biometrical Journal, 47, 662 – 673.
identifier.pub.URI
http://dx.doi.org/10.1002/bimj.200510157
description.abstractThis paper addresses treatment effect heterogeneity (also referred to, more compactly, as treatment heterogeneity) in the context of a controlled clinical trial with binary endpoints. Treatment heterogeneity, variation in the true (causal) individual treatment effects, is explored using the concept of the potential outcome. This framework supposes the existance of latent responses for each subject corresponding to each possible treatment. In the context of a binary endpoint, treatment heterogeniety may be represented by the parameter, 2, the probability that an individual would have a failure on the experimental treatment, if received, and would have a success on control, if received. Previous research derived bounds for 2 based on matched pairs data. The present research extends this method to the blocked data context. Estimates (and their variances) and confidence intervals for the bounds are derived. We apply the new method to data from a renal disease clinical trial. In this example, bounds based on the blocked data are narrower than the corresponding bounds based only on the marginal success proportions. Some remaining challenges (including the possibility of further reducing bound widths) are discussed. (© 2005 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim)
typeArticle - Journal
type.DCMITypetext
type.statusPostprint
rightsThis material is presented to ensure timely dissemination of scholarly and technical work. Copyright and all rights therein are retained by authors or by other copyright holders. All persons copying this information are expected to adhere to the terms and constraints invoked by each author's copyright. In most cases, these works may not be reposted without the explicit permission of the copyright holder.
rights.URI
http://www.wiley.com/WileyCDA/Section/id-301854.html
relation.isPartOfBiometrical Journal
date.accessioned2007-04-11T17:00:48Z
date.available2008-05-07T19:02:02Z
identifier.persist.URI
http://scholarsmine.mst.edu/post_prints/AssessingTreatmentEffectHeteroge_09007dcc804f0868.html